CLINICAL_TRIALS
trial_result
· 2019-07-22
Clinical Trial Update: Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) [Phase 4]
Summary
Phase 4 trial update comparing Macular Epiretinal Brachytherapy to Lucentis-only treatment for macular degeneration; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King's College Hospital NHS Trust | Conditions: Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2019-07-22